Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;25(1):29-40.
doi: 10.1007/s40291-020-00509-z. Epub 2021 Jan 12.

The Ubiquitin Proteasome System and Skin Fibrosis

Wanlu Shen #  1 , Zhigang Zhang #  1 , Jiaqing Ma #  2 , Di Lu  1 , Lechun Lyu  3
Affiliations
Review

The Ubiquitin Proteasome System and Skin Fibrosis

Wanlu Shen et al. Mol Diagn Ther. 2021 Jan.

Abstract

The ubiquitin proteasome system (UPS) is a highly conserved way to regulate protein turnover in cells. The UPS hydrolyzes and destroys variant or misfolded proteins and finely regulates proteins involved in differentiation, apoptosis, and other biological processes. This system is a key regulatory factor in the proliferation, differentiation, and collagen secretion of skin fibroblasts. E3 ubiquitin protein ligases Parkin and NEDD4 regulate multiple signaling pathways in keloid. Tumor necrosis factor (TNF) receptor-associated factor 4 (TRAF4) binding with deubiquitinase USP10 can induce p53 destabilization and promote keloid-derived fibroblast proliferation. The UPS participates in the occurrence and development of hypertrophic scars by regulating the transforming growth factor (TGF)-β/Smad signaling pathway. An initial study suggests that TNFα-induced protein 3 (TNFAIP3) polymorphisms may be significantly associated with scleroderma susceptibility in individuals of Caucasian descent. Sumoylation and multiple ubiquitin ligases, including Smurfs, UFD2, and KLHL42, play vital roles in scleroderma by targeting the TGF-β/Smad signaling pathway. In the future, drugs targeting E3 ligases and deubiquitinating enzymes have great potential for the treatment of skin fibrosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zhao X, Psarianos P, Ghoraie LS, Yip K, Goldstein D, Gilbert R, et al. Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis. Nat Metab. 2019;1(1):147–57. https://doi.org/10.1038/s42255-018-0008-5 . - DOI - PubMed
    1. Griffin MF, des Jardins-Park HE, Mascharak S, Borrelli MR, Longaker MT. Understanding the impact of fibroblast heterogeneity on skin fibrosis. Dis Models Mech. 2020. https://doi.org/10.1242/dmm.044164 . - DOI
    1. Do NN, Eming SA. Skin fibrosis: models and mechanisms. Curr Res Transl Med. 2016;64(4):185–93. https://doi.org/10.1016/j.retram.2016.06.003 . - DOI - PubMed
    1. Li Y, Zhang J, Lei Y, Lyu L, Zuo R, Chen T. MicroRNA-21 in skin fibrosis: potential for diagnosis and treatment. Mol Diagn Ther. 2017;21(6):633–42. https://doi.org/10.1007/s40291-017-0294-8 . - DOI - PubMed
    1. Coentro JQ, Pugliese E, Hanley G, Raghunath M, Zeugolis DI. Current and upcoming therapies to modulate skin scarring and fibrosis. Adv Drug Deliv Rev. 2019;146:37–59. https://doi.org/10.1016/j.addr.2018.08.009 . - DOI - PubMed

Publication types

Substances